Search Results | Diabetes Care | American Diabetes Association

1-20 of 163

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts

Caroline A. Thompson, Til Stürmer

Diabetes Care 2023;46(2):249–251

DOI: https://doi.org/10.2337/dci22-0052

Published: 16 December 2022

View article

Journal Articles

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Sara J. Cromer, Julie C. Lauffenburger, Raisa Levin, Elisabetta Patorno

Diabetes Care 2023;46(1):65–74

DOI: https://doi.org/10.2337/dc22-0383

Published: 16 November 2022

View article

Journal Articles

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

Julien Bezin, Amandine Gouverneur, Marine Pénichon, Clément Mathieu, Renaud Garrel, Dominique Hillaire-Buys, Antoine Pariente, Jean-Luc Faillie

Diabetes Care 2023;46(2):384–390

DOI: https://doi.org/10.2337/dc22-1148

Published: 10 November 2022

View article

Journal Articles

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, Robert A. Gabbay, Jennifer Green, Nisa M. Maruthur, Sylvia E. Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Tsvetalina Tankova, Apostolos Tsapas, John B. Buse

Diabetes Care 2022;45(11):2753–2786

DOI: https://doi.org/10.2337/dci22-0034

Published: 28 September 2022

View article

Journal Articles

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

Julio A. Lamprea-Montealegre, Erin Madden, Sri Lekha Tummalapalli, Chi D. Chu, Carmen A. Peralta, Yuxian Du, Rakesh Singh, Sheldon X. Kong, Delphine S. Tuot, Michael G. Shlipak, Michelle M. Estrella

Diabetes Care 2022;45(12):2900–2906

DOI: https://doi.org/10.2337/dc22-0614

Published: 23 September 2022

View article

Journal Articles

Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes

Richeek Pradhan, Hui Yin, Oriana H.Y. Yu, Laurent Azoulay

Diabetes Care 2022;45(10):2289–2298

DOI: https://doi.org/10.2337/dc22-0712

Published: 22 July 2022

View article

Journal Articles

Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes

Klara R. Klein, Virginia Pate, Magdalene M. Assimon, Til Stürmer, John B. Buse, Jennifer E. Flythe

Diabetes Care 2022;45(9):126–128

DOI: https://doi.org/10.2337/dc22-0659

Published: 21 July 2022

View article

Journal Articles

Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial

Juan Pablo Frias, JaeDuk Choi, Julio Rosenstock, Luiza Popescu, Elisabeth Niemoeller, Isabel Muehlen-Bartmer, Seungjae Baek

Diabetes Care 2022;45(7):1592–1600

DOI: https://doi.org/10.2337/dc21-2656

Published: 06 July 2022

View article

Journal Articles

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge

Darko Stefanovski, Mary E. Vajravelu, Stephanie Givler, Diva D. De León

Diabetes Care 2022;45(6):1381–1390

DOI: https://doi.org/10.2337/dc21-2009

Published: 13 April 2022

View article

Journal Articles

GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease

Yi-Sun Yang, Hsin-Hung Chen, Chien-Ning Huang, Chung Y. Hsu, Kai-Chieh Hu, Chia-Hung Kao

Diabetes Care 2022;45(5):1184–1192

DOI: https://doi.org/10.2337/dc21-1993

Published: 11 March 2022

View article

Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes

Richeek Pradhan, Hui Yin, Oriana Yu, Laurent Azoulay

Diabetes Care 2022;45(4):819–829

DOI: https://doi.org/10.2337/dc21-1953

Published: 01 February 2022

View article

Journal Articles

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Liang Chen, Mahmoud Al Rifai, Julia M. Akeroyd, Elizabeth M. Vaughan, Michael E. Matheny, Karla Rodrigues do Espirito Santo, Sankar D. Navaneethan, Carl J. Lavie, Yochai Birnbaum, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani

Diabetes Care 2022;45(2):372–380

DOI: https://doi.org/10.2337/dc21-1815

Published: 17 January 2022

View article

Journal Articles

The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study

Alexander Dimitri Miras, Anna Kamocka, Belén Pérez-Pevida, Sanjay Purkayastha, Krishna Moorthy, Ameet Patel, Harvinder Chahal, Gary Frost, Paul Bassett, Lidia Castagnetto-Gissey, Lucy Coppin, Nicola Jackson, Anne Margot Umpleby, Stephen Robert Bloom, Tricia Tan, Ahmed Rashid Ahmed, Francesco Rubino

Diabetes Care 2021;44(5):1082–1090

DOI: https://doi.org/10.2337/dc20-0762

Published: 06 November 2021

View article

Journal Articles

Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19

Pandora L. Wander, Elliott Lowy, Lauren A. Beste, Luis Tulloch-Palomino, Anna Korpak, Alexander C. Peterson, Steven E. Kahn, Edward J. Boyko

Diabetes Care 2021;44(12):2708–2713

DOI: https://doi.org/10.2337/dc21-1351

Published: 06 October 2021

View article

Journal Articles

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa A. Haendel, Klara R. Klein, Hemalkumar Mehta, Joshua D. Miller, Richard A. Moffitt, Til Stürmer, Kajsa Kvist, John B. Buse, N3C Consortium, Tim Q. Duong

Diabetes Care 2021;44(7):1564–1572

DOI: https://doi.org/10.2337/dc21-0065

Published: 20 July 2021

View article

Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

Guillaume Marquis-Gravel, Jean-Claude Tardif

Diabetes Care 2021;44(6):1252–1253

DOI: https://doi.org/10.2337/dci20-0076

Published: 18 June 2021

View article

Journal Articles

Application of 2021 American Diabetes Association Glycemic Treatment Clinical Practice Recommendations in Primary Care

Caitlin Colling, Steven J. Atlas, Deborah J. Wexler

Diabetes Care 2021;44(6):1443–1446

DOI: https://doi.org/10.2337/dc21-0013

Published: 18 June 2021

View article

Journal Articles

Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes

Tatsuya Fukuda, Ryotaro Bouchi, Takato Takeuchi, Kikuko Amo-Shiinoki, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe, Takumi Akashi, Kazuhiro Hirayama, Toshitaka Odamaki, Miki Igarashi, Ikuo Kimura, Katsuya Tanabe, Yukio Tanizawa, Tetsuya Yamada, Yoshihiro Ogawa

Diabetes Care 2021;44(4):1002–1011

DOI: https://doi.org/10.2337/dc20-0864

Published: 24 February 2021

View article

Journal Articles

Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study

Lawrence Blonde, Julio Rosenstock, Juan Frias, Andreas L. Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, Vanita R. Aroda

Diabetes Care 2021;44(3):774–780

DOI: https://doi.org/10.2337/dc20-2023

Published: 19 January 2021

View article

Journal Articles

Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study

Ibiyemi Ilesanmi, George Tharakan, Kleopatra Alexiadou, Preeshila Behary, Haya Alessimii, Candace Bovill-Taylor, Julia Kenkre, Sirazum Choudhury, Chedie Doyle, Sanjay Purkayastha, Alex Miras, Christos Tsironis, Harvinder Chahal, Stephen R. Bloom, Nick S. Oliver, Ahmed R. Ahmed, Bernard Khoo, Tricia M.-M. Tan

Diabetes Care 2021;44(2):614–617

DOI: https://doi.org/10.2337/dc20-1609

Published: 17 December 2020

View article

2 3 4 5

NARROW

Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes

Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes

Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge

GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease

Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study

Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

Application of 2021 American Diabetes Association Glycemic Treatment Clinical Practice Recommendations in Primary Care

Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes

Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study

Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only